These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

451 related articles for article (PubMed ID: 2250662)

  • 1. Characterization of muscarinic M4 binding sites in rabbit lung, chicken heart, and NG108-15 cells.
    Lazareno S; Buckley NJ; Roberts FF
    Mol Pharmacol; 1990 Dec; 38(6):805-15. PubMed ID: 2250662
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antagonist binding properties of five cloned muscarinic receptors expressed in CHO-K1 cells.
    Buckley NJ; Bonner TI; Buckley CM; Brann MR
    Mol Pharmacol; 1989 Apr; 35(4):469-76. PubMed ID: 2704370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinct kinetic binding properties of N-[3H]-methylscopolamine afford differential labeling and localization of M1, M2, and M3 muscarinic receptor subtypes in primate brain.
    Flynn DD; Mash DC
    Synapse; 1993 Aug; 14(4):283-96. PubMed ID: 8248852
    [TBL] [Abstract][Full Text] [Related]  

  • 4. M1 and M3 muscarinic receptor subtypes in rat forebrain.
    Pavia J; Marquez E; Laukkonen S; Martos F; Gómez A; Sánchez de la Cuesta F
    Methods Find Exp Clin Pharmacol; 1991 Dec; 13(10):653-60. PubMed ID: 1770828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The quaternary transformation products of N-(3-chloropropyl)-4-piperidinyl diphenylacetate and N-(2-chloroethyl)-4-piperidinyl diphenylacetate (4-DAMP mustard) have differential affinity for subtypes of the muscarinic receptor.
    Ehlert FJ; Oliff HS; Griffin MT
    J Pharmacol Exp Ther; 1996 Feb; 276(2):405-10. PubMed ID: 8632303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Muscarinic receptor heterogeneity in rat central nervous system. II. Brain receptors labeled by [3H]oxotremorine-M correspond to heterogeneous M2 receptors with very high affinity for agonists.
    Gillard M; Waelbroeck M; Christophe J
    Mol Pharmacol; 1987 Jul; 32(1):100-8. PubMed ID: 3600611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of muscarinic receptors in human, guinea pig and rat lung.
    Gies JP; Bertrand C; Vanderheyden P; Waeldele F; Dumont P; Pauli G; Landry Y
    J Pharmacol Exp Ther; 1989 Jul; 250(1):309-15. PubMed ID: 2746503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Irreversible and quaternary muscarinic antagonists discriminate multiple muscarinic receptor binding sites in rat brain.
    Norman AB; Eubanks JH; Creese I
    J Pharmacol Exp Ther; 1989 Mar; 248(3):1116-22. PubMed ID: 2703964
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radioligand binding characteristics of the chicken cardiac muscarinic receptor.
    Michel AD; Whiting RL
    Naunyn Schmiedebergs Arch Pharmacol; 1989 Sep; 340(3):279-84. PubMed ID: 2812039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Binding of selective antagonists to four muscarinic receptors (M1 to M4) in rat forebrain.
    Waelbroeck M; Tastenoy M; Camus J; Christophe J
    Mol Pharmacol; 1990 Aug; 38(2):267-73. PubMed ID: 2385234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tetrahydroaminoacridine and other allosteric antagonists of hippocampal M1 muscarine receptors.
    Potter LT; Ferrendelli CA; Hanchett HE; Hollifield MA; Lorenzi MV
    Mol Pharmacol; 1989 May; 35(5):652-60. PubMed ID: 2725474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of antisera selective for m4 and m5 muscarinic cholinergic receptors: distribution of m4 and m5 receptors in rat brain.
    Yasuda RP; Ciesla W; Flores LR; Wall SJ; Li M; Satkus SA; Weisstein JS; Spagnola BV; Wolfe BB
    Mol Pharmacol; 1993 Feb; 43(2):149-57. PubMed ID: 8429821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gallamine binding to muscarinic M1 and M2 receptors, studied by inhibition of [3H]pirenzepine and [3H]quinuclidinylbenzilate binding to rat brain membranes.
    Burke RE
    Mol Pharmacol; 1986 Jul; 30(1):58-68. PubMed ID: 3755217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibodies to a synthetic peptide can be used to distinguish between muscarinic acetylcholine receptor binding sites in brain and heart.
    Luthin GR; Harkness J; Artymyshyn RP; Wolfe BB
    Mol Pharmacol; 1988 Sep; 34(3):327-33. PubMed ID: 3419425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Affinity of muscarinic receptor antagonists for three putative muscarinic receptor binding sites.
    Delmendo RE; Michel AD; Whiting RL
    Br J Pharmacol; 1989 Feb; 96(2):457-64. PubMed ID: 2924085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective labeling and localization of the M4 (m4) muscarinic receptor subtype.
    Ferrari-Dileo G; Waelbroeck M; Mash DC; Flynn DD
    Mol Pharmacol; 1994 Dec; 46(6):1028-35. PubMed ID: 7808421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional and binding studies with muscarinic M2-subtype selective antagonists.
    Lazareno S; Roberts FF
    Br J Pharmacol; 1989 Sep; 98(1):309-17. PubMed ID: 2804551
    [TBL] [Abstract][Full Text] [Related]  

  • 18. M2, M3 and M4, but not M1, muscarinic receptor subtypes are present in rat spinal cord.
    Höglund AU; Baghdoyan HA
    J Pharmacol Exp Ther; 1997 Apr; 281(1):470-7. PubMed ID: 9103533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [3H]pirenzepine and (-)-[3H]quinuclidinyl benzilate binding to rat cerebral cortical and cardiac muscarinic cholinergic sites. II. Characterization and regulation of antagonist binding to putative muscarinic subtypes.
    Watson M; Roeske WR; Yamamura HI
    J Pharmacol Exp Ther; 1986 May; 237(2):419-27. PubMed ID: 3754581
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction of neuromuscular blocking drugs with recombinant human m1-m5 muscarinic receptors expressed in Chinese hamster ovary cells.
    Cembala TM; Sherwin JD; Tidmarsh MD; Appadu BL; Lambert DG
    Br J Pharmacol; 1998 Nov; 125(5):1088-94. PubMed ID: 9846649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.